Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 10, 2019
Reporting Period: First fiscal quarter ended March 31, 2019
Context: This filing serves to announce the company's financial results for the first quarter of 2019. The detailed results are contained in a press release incorporated by reference as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data points. The filing references a press release (Exhibit 99.1) for the actual figures. Consequently, the following metrics are not available in the source text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the incorporated press release (Exhibit 99.1) for year-over-year or quarter-over-quarter analysis.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. These disclosures are expected to be found within the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 10, 2019) for actual Q1 2019 revenue, net income, and cash flow figures.
- Verify year-over-year growth rates and margin trends in the full press release.
- Check for any updated financial guidance or operational outlook provided in the press release.
- Confirm the status of the company's liquidity and debt obligations as detailed in the full financial report.